In the liver of WD/TN mice, TLC-065 elevated the levels of NAD+ and the associated salvage metabolites, including NR, NAMN and NAM without impacting levels of metabolites upstream of ACMSD, e.g. KYN and KYN acid (Fig. 6E and Fig. S5E). Here, ACMSD is linked to Wilson disease.